Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety Study of ACP-104: To Demonstrate the Safety, Tolerability, and Pharmacokinetics

This study has been completed.
Sponsor:
Collaborators:
Stanley Medical Research Institute
ACADIA Pharmaceuticals Inc.
Information provided by:
University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT00628420
First received: February 24, 2008
Last updated: June 27, 2011
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: November 2006 (Final data collection date for primary outcome measure)